Navigation Links
Aflac Duck Takes Care of Business
Date:5/19/2008

New B-to-B ads explain why 400,000 U.S. companies already provide Aflac to

workers

COLUMBUS, Ga., May 19 /PRNewswire/ -- Aflac Incorporated has launched its new business-to-business television commercials as part of its "Aflac for Business" campaign. The television spots feature the iconic Aflac Duck and target corporations and small businesses that are interested in enhancing employee benefits with no direct impact on company costs.

According to a Kaiser Foundation employee health benefits survey* released in 2007, employment-based health insurance premiums have increased by 100 percent since 2000. Further, a Mercer health and benefits survey** conducted in 2007 predicts that in 2008 the average health plan costs per employee will rise to $8,500, up from $7,523 in 2006, giving companies pause to drop or reduce employee benefits. Aflac's new campaign shows how employers can help provide solutions by making Aflac insurance policies available -- including accident, short-term disability, hospital confinement indemnity and long-term care -- at no direct charge to the business.

"As rising costs are forcing companies to clamp down on spending, Aflac helps employers provide more benefits with no direct cost to businesses," said Paul Amos II, president and chief operating officer, Aflac U.S. "Aflac insurance can help businesses retain valued employees and market themselves to the best workers in the most competitive markets."

The humorous campaign, produced by New York-based Kaplan Thaler Group, currently features the Aflac Duck in a series of print, radio and online advertisements. In the new commercials the duck navigates his way through a variety of typically unusual settings, including a hospital nursery, a shoe store, a restaurant and resort, where he educates businesses, large and small, on how to improve benefits and avoid additional costs by providing Aflac products. The ads will run primarily on b
'/>"/>

SOURCE Aflac Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Aflac Announces Resignation of U.S. Marketing Officer
2. Aflac Incorporated to Release Third Quarter Results On October 23, 2007
3. Aflac Incorporated Announces Third Quarter Results, Declares Fourth Quarter Cash Dividend
4. Aflac Honors Hispanic Entrepreneurs Making a Difference in Texas
5. Aflac Japan To Offer Cancer Insurance Product Through Japan Post
6. Aflac Incorporated to Present at the Goldman Sachs Financial Services CEO Conference 2007
7. Aflac to Sponsor Iron Girl
8. Aflac Incorporated to Accelerate Share Repurchase in 2008; Authorizes Additional Share Repurchase and Increases Quarterly Cash Dividend 17.1%
9. Aflac Incorporated Announces Fourth Quarter Results
10. Training Magazine Applauds Aflacs Employee Learning Programs
11. Aflac Incorporated to Present at the Raymond James 29th Annual Institutional Investors Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)...TOWN, Ariz., Dec. 3 The ...ay that it has acquired SunView Care Center, an op...Youngtown, Arizona, a sister community adjacent to...isition was effective December 1, 2009. ,, (Log...LATH168LOGO ) ,, "We are pleased to be adding ...
(Date:12/3/2009)...RBOR, Mich., Dec. 3 A majority of ...reform legislation, but most lack confidence that ...al care will improve in the next year, according t..., Sixty percent of survey respondents said they be...healthcare reform legislation. Only about one in f...
(Date:12/2/2009)...RAPIDS, Mich., Dec. 3 Van Andel Re...d precisely how the plant hormone abscisic acid (A...spond to environmental stresses such as drought an... Nature , could help engineer crops that thrive in...obal food shortages. The findings could also have...
(Date:12/2/2009)...EW YORK, Dec. 2 Reportlinker.com a...lable in its catalogue: ,, Sterilization Tech...rtlinker.com/p0166820/Sterilization-Technologies-T...n sales of capital equipment to the sterilization ...und annual growth rate for 2009-2014. ,, Explai...
(Date:12/2/2009)...NEW YORK, Dec. 2 Reportlinker.com ...ilable in its catalogue: ,, Kinase Inhibitors....com/p0166819/Kinase-Inhibitors-Global-Markets.htm...ing data for the years 2005 through 2008, and proj...rates (CAGRs) through 2014 ,, An overview of t...
Breaking Medicine News(10 mins):Health News:The Ensign Group Acquires Arizona Skilled Nursing Facility 2Health News:Thomson Reuters Survey: Most Americans Support Public Option in Healthcare Reform Legislation but Are Skeptical Healthcare Will Improve in 2010 2Health News:VAI Researchers Find Long Awaited Key to Creating Drought Resistant Crops 2Health News:VAI Researchers Find Long Awaited Key to Creating Drought Resistant Crops 3Health News:VAI Researchers Find Long Awaited Key to Creating Drought Resistant Crops 4Health News:Reportlinker Adds Sterilization Technologies: The U.S. Market 2Health News:Reportlinker Adds Sterilization Technologies: The U.S. Market 3Health News:Reportlinker Adds Sterilization Technologies: The U.S. Market 4Health News:Reportlinker Adds Sterilization Technologies: The U.S. Market 5Health News:Reportlinker Adds Sterilization Technologies: The U.S. Market 6Health News:Reportlinker Adds Sterilization Technologies: The U.S. Market 7Health News:Reportlinker Adds Sterilization Technologies: The U.S. Market 8Health News:Reportlinker Adds Sterilization Technologies: The U.S. Market 9Health News:Reportlinker Adds Sterilization Technologies: The U.S. Market 10Health News:Reportlinker Adds Sterilization Technologies: The U.S. Market 11Health News:Reportlinker Adds Sterilization Technologies: The U.S. Market 12Health News:Reportlinker Adds Sterilization Technologies: The U.S. Market 13Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 2Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 3Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 4Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 5Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 6Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 7Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 8Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 9Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 10Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 11Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 12Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 13Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 14Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 15
...on suggests that daily use of inhaled steroids may... Dr. Gregory Sawicki insists that a stud... shown that over a period of one-year, children wh... The findings remained same even when the sever...
...eth's oral contraceptive Lybrel, which is designed...ngeles Times reports. Lybrel, which contains a lo...n traditional oral contraceptives, is taken 365 da... According to Wyeth, 59% of women taking Lybr...
...joined forces with Canadian biotech company GangaG... fight against food poisoning . They are e...hods for the control of Campylobacter the commone...ry and other animals and cause millions of cases o...
...ditions for nurses are safer for elderly intensive...eport , led by researchers that measured rates of...ed infections are the number six cause of death in...ety of ICUs if systematic improvements to their wo...
...ck have found that sexual orientation has a real e...ating with a map in a car but that old age does n...nd withers all mens minds alike just ahead of wome... women). As expected they found men outperformed w...
...nts with asthma are more likely to have severe ast.... The study was conducted by a team of res...and colleagues at Emory University. As par... one of the largest diverse surveys of all asthma ...
Other Medicine News:Health News:Use of Inhaled Steroids on Daily Basis may Not Control Childhood Asthma 2Health News:FDA Approves Wyeth's Oral Contraceptive Lybrel 2Health News:Experts to Develop New Weapons Against Food Poisoning 2Health News:Experts to Develop New Weapons Against Food Poisoning 3Health News:Better Working Conditions for Nurses Might Decrease Patient Infections 2Health News:Better Working Conditions for Nurses Might Decrease Patient Infections 3Health News:Obesity Might Lead to Severe Persistent Asthma Attacks: Study 2
(Date:12/2/2009)...ewswire-FirstCall/ -- Cephalon, Inc. (Nasdaq: CEP... U.S. District Court in Delaware against Teva Phar...ent Nos. 7,132,570 (the ",570 Patent"), 7,297,346 ...") for the Cephalon product NUVIGIL® (armodaf...eriod of marketing exclusivity for NUVIGIL that ex...
(Date:12/2/2009)...wswire/ -- Reportlinker.com announces that a new m...e: ,, Pharmaceutical Contract Manufacturing -...inker.com/p0164248/Pharmaceutical-Contract-Manufac... pharma industry faces numerous challenges in the ... rising cost of new product development, declining...
(Date:12/2/2009)...ewswire-USNewswire/ -- Jupiter Medical Center ha... tools available into its imaging program, the new... system delivers highly detailed images of the hum...d unique applications, including dual breast scann... with renal dysfunction. This results in shorter ...
Breaking Medicine Technology:Cephalon Files Patent Infringement Lawsuit Against Teva Pharmaceuticals 2Cephalon Files Patent Infringement Lawsuit Against Teva Pharmaceuticals 3Cephalon Files Patent Infringement Lawsuit Against Teva Pharmaceuticals 4Reportlinker Adds Pharmaceutical Contract Manufacturing - Global Market Trends 2Reportlinker Adds Pharmaceutical Contract Manufacturing - Global Market Trends 3Reportlinker Adds Pharmaceutical Contract Manufacturing - Global Market Trends 4Reportlinker Adds Pharmaceutical Contract Manufacturing - Global Market Trends 5Jupiter Medical Center Announces New High-Definition MRI System 2Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 1Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 2Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 3Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 4Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 5Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 6Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 7Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 8Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 9Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 10Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 11Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 12Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 13Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 14Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 15State of Oklahoma Offers Invisible Bracelet Health Benefit 57571 1State of Oklahoma Offers Invisible Bracelet Health Benefit 57571 2Immucor to Announce Fiscal First Quarter Financial Results on Thursday October 1 2009 57569 1
...w comparable safety for complex patients treated w...y , , NATICK, Mass., Feb. 18 Boston Scientific C...cation of results from its landmark SYNTAX(TM) tri... of Medicine. In the study, percutaneous coronary...) Paclitaxel-Eluting Coronary Stent System was com...
...TLE, Feb. 18 Cell Therapeutics, Inc.,(Nasdaq and ... efficacy data,from the phase III trial of pixantr... benefit for pixantrone when used as single agent ...essive non-Hodgkin,s lymphoma (NHL). On an,intent-...ved a complete,remission did so during the first 2...
Other Medicine Technology:New England Journal of Medicine Publishes Results from Boston Scientific's Landmark SYNTAX(TM) Trial 2New England Journal of Medicine Publishes Results from Boston Scientific's Landmark SYNTAX(TM) Trial 3New England Journal of Medicine Publishes Results from Boston Scientific's Landmark SYNTAX(TM) Trial 4New England Journal of Medicine Publishes Results from Boston Scientific's Landmark SYNTAX(TM) Trial 5Compared to Standard Therapies, Pixantrone Decreases Time to Achieve Complete Remission by 47% in Relapsed Aggressive Non-Hodgkin's Lymphoma 2Compared to Standard Therapies, Pixantrone Decreases Time to Achieve Complete Remission by 47% in Relapsed Aggressive Non-Hodgkin's Lymphoma 3Compared to Standard Therapies, Pixantrone Decreases Time to Achieve Complete Remission by 47% in Relapsed Aggressive Non-Hodgkin's Lymphoma 4
Magic WALLSTENT® Stent System
...edical's universal programmer platform, the Model ...th St. Jude Medical® bradycardia and tachycard...tions. Features a large, color display on a touch...fers continuous, simultaneous display of surface E...
Finnpipette 384
Liberte™ Coronary Stent System
Medicine Products: